Improving Prostate Cancer Care through Quality Assurance Programs

Main Article Content

Hans Veerman, MD
Marais Hagens, MD
André Vis, MD, PHD
Jeroen van Moorselaar, MD, PHD
Pim van Leeuwen, MD, PHD
Michel Wouters, MD, PHD
Henk van der Poel, MD, PHD


Continuous quality assurance assessment and control in healthcare is essential to provide patients with the best possible care. Quality assurance programs have been developed to improve future healthcare by thoroughly studying patient outcomes on a physician- or institutional-level. Through the continuous and cyclical process of data registration, evaluation and adaptation, opportunities are sought to improve (individual) patient outcomes. Over the past decade, quality assurance programs have been initiated within urological clinical practice, mainly focusing on the diagnosis and surgical treatment of prostate cancer. While they all share the same philosophy to improve healthcare, existing quality assurance programs differ greatly. To date, little is known about their effects on the outcomes of prostate cancer care. In this chapter, we summarize the current knowledge regarding quality assurance program within prostate cancer care. We provide insights into how quality Assurance programs can improve and assure future diagnosis and treatment of prostate cancer.


Download data is not yet available.


Metrics Loading ...

Article Details

Chapter 14